25
Participants
Start Date
March 31, 2021
Primary Completion Date
April 30, 2024
Study Completion Date
December 31, 2024
Patient treated by Avapritinib in real life
"The patients included are treated with Avapritinib as part of their care. There is no change in treatment associated with this study.~Patients must regularly complete various questionnaires: FACT-G, FACT-COG, and a neuropsychiatrist or a trained physician will give them the MoCA."
Centre Léon Bérard, Lyon
CHRU Besançon, Besançon
Insitut Bergonié, Bordeaux
CHU Clermont Ferrand, Clermont-Ferrand
Institut de Cancérologie de l'Ouest (ICO), Nantes
CHU Robert Debré, Reims
Institut Gustave Roussy, Villejuif
Collaborators (1)
Blueprint Medicines Corporation
INDUSTRY
Centre Leon Berard
OTHER